
Delirium: Acute Confusional State
Definition:
Delirium is an acute, fluctuating disturbance in attention, awareness, and cognition that develops over hours to days. It represents a medical emergency requiring immediate evaluation.
Key Diagnostic Criteria (DSM-5):
- Disturbed attention (reduced ability to focus/sustain/shift attention)
- Acute onset (hours to days) with daily fluctuations
- Additional cognitive disturbance (memory, orientation, language, visuospatial)
- Not better explained by pre-existing neurocognitive disorder
- Evidence of underlying medical cause, intoxication, or medication effect
Clinical Features:
| Domain | Manifestations |
|---|---|
| Attention | Easily distracted, unable to follow conversations |
| Consciousness | Reduced awareness of environment |
| Cognition | Disorientation, memory deficits, incoherent speech |
| Perception | Hallucinations (often visual), illusions |
| Psychomotor | Hyperactive (agitated) or hypoactive (lethargic) subtypes |
| Sleep-Wake | Reversed cycle, daytime drowsiness |
Subtypes:
- Hyperactive Delirium (15-25%)
- Agitation, hallucinations, combativeness
- More easily recognized
- Hypoactive Delirium (50-75%)
- Lethargy, decreased responsiveness
- Often missed (“quiet confusion”)
- Mixed Type (50%)
- Fluctuates between hyper/hypoactive states
Common Causes (I WATCH DEATH Mnemonic):
I – Infection (UTI, pneumonia, sepsis)
W – Withdrawal (alcohol, benzodiazepines)
A – Acute metabolic (electrolytes, glucose, liver/renal failure)
T – Trauma (head injury, post-op)
C – CNS pathology (stroke, seizures, meningitis)
H – Hypoxia (COPD, heart failure, anemia)
D – Deficiencies (B12, thiamine)
E – Endocrine (thyroid, adrenal)
A – Acute vascular (shock, MI)
T – Toxins/drugs (anticholinergics, opioids, polypharmacy)
H – Heavy metals
Risk Factors:
- Patient Factors: Older age, dementia, multiple comorbidities
- Hospital Factors: ICU admission, physical restraints, bladder catheters
- Medications: Opioids, benzodiazepines, anticholinergics
Assessment Tools:
- Confusion Assessment Method (CAM) – Gold standard
- Acute onset + fluctuating course
- Inattention
- Disorganized thinking
- Altered consciousness
- 4AT Rapid Assessment (≥4 suggests delirium)
- Alertness, AMT4, attention, acute change
- Delirium Rating Scale (DRS-R-98) – Severity measure
Management:
1. Identify/Treat Underlying Cause
- Review medications (STOP anticholinergics/sedatives)
- Treat infections, correct metabolic derangements
2. Non-Pharmacologic Measures:
- Reorientation (clocks, calendars, family presence)
- Ensure adequate sleep (reduce nighttime interruptions)
- Early mobilization
- Sensory aids (glasses, hearing devices)
- Avoid physical restraints
3. Pharmacologic Therapy (LAST RESORT):
- 1st Line: Haloperidol (0.5-1mg PO/IM/IV)
- Alternatives: Atypical antipsychotics (risperidone, quetiapine)
- Contraindicated: Benzodiazepines (except alcohol/benzo withdrawal)
Complications:
- Increased mortality (up to 25% in hospitalized patients)
- Prolonged hospitalization
- Higher risk of dementia
- Functional decline
Prevention Strategies:
- Hospital Elder Life Program (HELP):
- Orientation
- Early mobilization
- Hearing/vision adaptations
- Sleep hygiene
- Volume/nutrition repletion
Prognosis:
- Typically resolves within days-weeks with treatment
- 30-40% may have symptoms persisting months
- Hypoactive delirium has worse outcomes
Differential Diagnosis:
- Dementia (chronic, no fluctuation)
- Depression (“pseudodelirium” with psychomotor slowing)
- Psychosis (no acute medical cause)
